Una Riekstiņa

This paper demonstrates that the GreenB1 aptamer specifically targets β1-integrin in triple-negative breast cancer cells and tumors, suggesting its potential for precision diagnosis and therapy.

The paper introduces a method to identify organ-specific peptides using differential binding analysis of in vivo phage display data, improving the efficiency and reproducibility of biopanning.

The paper introduces a differential binding cell-SELEX method using HTS to identify cell-specific aptamers, demonstrating improved selection rates against live cells.